Categories: Big DataNews

Evogene Schedules Third Quarter 2024 Financial Results Release

Zoom conference call scheduled for November 21, 2024, 9:00 AM ET

REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the third quarter of 2024, on Thursday, November 21, 2024.

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To join the conference, please register in advance:
https://us06web.zoom.us/webinar/register/WN_pG-Wc0JeQIifu1dmSUYOng

The entire conference will be available online on the company’s website a few days after.

About Evogene:

Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.

Evogene established three unique tech-engines – MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:

  1. Biomica Ltd. (www.biomicamed.com) – developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
  2. Lavie Bio Ltd. (www.lavie-bio.com)developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
  3. AgPlenus Ltd. (www.agplenus.com) – developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
  4. Casterra Ag Ltd. (www.casterra.co) – developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.

For more information, please visit: www.evogene.com.

Logo –  https://healthtechnologynet.com/wp-content/uploads/2024/11/Evogene_Logo.jpg

Contact
ir@evogene.com
Tel: +972-8-9311901

View original content:https://www.prnewswire.com/news-releases/evogene-schedules-third-quarter-2024-financial-results-release-302298582.html

SOURCE Evogene

Staff

Recent Posts

Cellev8 Nutrition Shareholder Update

WELLINGTON, FL / ACCESSWIRE / November 7, 2024 / Dear Valued Shareholders,I am thrilled to…

1 hour ago

Mammotome Introduces the First Ever, Single Insertion, Spring-Loaded Core Biopsy System

CINCINNATI, Nov. 7, 2024 /PRNewswire/ -- Mammotome is excited to unveil the Mammotome AutoCore™ Single…

4 hours ago

Independent Alliance formed to Drive Smart Hospital Advancement

The Alliance for Smart Healthcare Excellence to host the Smart Hospital Maturity Model survey WASHINGTON,…

4 hours ago

New England Biolabs® Expands Lyophilization Capabilities with Opening of Manufacturing Facility in the UK

New England Biolabs Lyophilization Sciences® further strengthens its ability to deliver a best-in-class solution for…

4 hours ago

BoomerangFX Ranked as Canada’s Fastest-Growing Healthcare SaaS Company and 6th Overall in Deloitte Canada’s Technology Fast 50™ for Second Consecutive Year

Global Expansion and Private Healthcare Specialization Drive Unprecedented Growth TORONTO, MIAMI, Nov. 7, 2024 /PRNewswire/…

4 hours ago

AliveCor’s Services & Solutions are Now Available to Veterans

VA physicians can now access the solutions through Federal Supply Schedule and Defense Logistics Agency…

4 hours ago